Institution
Third Affiliated Hospital of Harbin Medical University
Also known as: Harbin Medical University Cancer Hospital · 哈尔滨医科大学第三临床医学院
- 269running trials
- 93closed trials
- 9,371publications (OpenAlex)
Running trials
Not yet recruiting
A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC
Not yet recruiting
Not yet recruiting
Phase III Study of HS-20089 With Bevacizumab in Platinum-Sensitive Recurrent Ovarian Cancer
Recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19)
Not yet recruiting
Recruiting
SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma
Not yet recruiting
Not yet recruiting
Retlirafusp Alfa Combined With Chemotherapy or Fuzuloparib for Triple-Negative Breast Cancer
Recruiting
Recruiting
A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)
Recruiting
Recruiting
Not yet recruiting
Active, not recruiting
Induction Chemoimmunotherapy Followed by Deescalated Definitive Radiotherapy in Head and Neck Cancer
Active, not recruiting
Not yet recruiting
A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer
Not yet recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold Regions
Recruiting
A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
Recruiting
Recruiting
Recruiting
A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
Recruiting
Tamsulosin for Early Catheter Removal After Rectal Cancer Surgery
Active, not recruiting
Recruiting
Recruiting
A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
Recruiting
Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer
Recruiting
Not yet recruiting
Active, not recruiting
HS-20093 in Patients With Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
Recruiting
Recruiting
A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Showing 50 of 269.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer55 recruiting
- Colorectal cancer27 recruiting
- Gastric and oesophageal cancer20 recruiting
- Liver and biliary tract cancer19 recruiting
- Metastatic breast cancer15 recruiting
- Pancreatic cancer13 recruiting
- Head and neck cancer7 recruiting
- Endometrial cancer6 recruiting
- Triple-negative breast cancer6 recruiting
- Childhood cancers5 recruiting
- Diffuse large B-cell lymphoma5 recruiting
- Ovarian cancer4 recruiting
- Bladder cancer3 recruiting
- Neuroendocrine tumours3 recruiting
- Cervical cancer2 recruiting
- Chronic lymphocytic leukaemia2 recruiting
- Kidney cancer2 recruiting
- Mantle cell lymphoma2 recruiting
- Melanoma2 recruiting
- Multiple myeloma2 recruiting
- Prostate cancer2 recruiting
- Thyroid cancer2 recruiting
- Brain metastases1 recruiting
- Sarcoma1 recruiting
Closed trials
Terminated
Recruiting
Completed
Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
Terminated
Recruiting
Completed
Completed
ARTEMIS-008:HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer
Recruiting
Completed
Completed
A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer
Recruiting
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903
Completed
Recruiting
Terminated
Completed
A Study of PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPM
Completed
Completed
Completed
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
Completed
Completed
Recruiting
Completed
Completed
Completed
Terminated
Terminated
Terminated
AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer
Recruiting
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901
Completed
Completed
Completed
Completed
Completed
Completed
The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma
Showing 50 of 93.
Registry name variants (42)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Harbin Medical University Cancer Hospital
Harbin, 150000
296 trials
Harbin Medical University cancer hospital
Ha’erbin, 150040
10 trials
Harbin medical university cancer hospital
Heilongjiang, Harbin 150081
8 trials
Harbin Medical University Cancer Hospital
Haerbin, Heilongjiang 150081
7 trials
Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin, Heilongjiang Province, China
Harbin, Heilongjiang 150081
2 trials
Harbin Medical University Cancer Hospital (Site 0007)
Harbin, Heilongjiang 150081
2 trials
Harbin Medical University Cancer Hospital (Site 0133)
Harbin, Heilongjiang 610000
2 trials
The Third Affiliated Hospital of Harbin Medical University (Site 0100)
Harbin, Heilongjiang 150081
2 trials
The Third Affiliated Hospital of Harbin Medical University (Site 3302)
Harbin, Heilongjiang 150081
2 trials
Harbin Medical University Cancer Hospital-Harbin Medical University Cancer Hospital (Site 3005)
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital - Oncology
Harbin, Heilongjiang
1 trial
NCT06901531A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Contact: Astellas Pharma Global Development Inc.
Harbin Medical University Cancer Hospital/Oncology Department
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital (Site 0089)
Harbin, Heilongjiang 610000
1 trial
Harbin Medical University Cancer Hospital (Site 0119)
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital (Site 0711)
Harbin, Heilongjiang 150000
1 trial
Harbin Medical University Cancer Hospital (Site 0750)
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital (Site 0822)
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital (Site 0847)
Harbin, Heilongjiang 150081
1 trial
Contact: Study Coordinator
Harbin Medical University Cancer Hospital (Site 0850)
Harbin, Heilongjiang 150000
1 trial
Harbin Medical University Cancer Hospital (Site 1013)
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital (Site 1606)
Harbin, Heilongjiang 150081
1 trial
Contact: Study Coordinator
Harbin Medical University Cancer Hospital (Site 1772)
Harbin, Heilongjiang 150000
1 trial
Harbin Medical University Cancer Hospital (Site 2401)
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital (Site 2407)
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital (Site 2410)
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital (Site 2520)
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital (Site 3109)
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital (Site 3123)
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital (Site 4033)
Harbin, Heilongjiang 150081
1 trial
Harbin Medical University Cancer Hospital (Site 5010)
Harbin, Heilongjiang 150000
1 trial
Harbin Medical University Cancer Hospital (Site 8009)
Harbin, Heilongjiang
1 trial
Harbin Medical University University Cancer Hospital
Harbin, Heilongjiang
1 trial
Contact: Yanqiao Zhang
The Third Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang 150000
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Lung cancer170 works · 123 trials
- Liver and biliary tract cancer74 works · 39 trials
- Gastric and oesophageal cancer68 works · 50 trials
- Colorectal cancer64 works · 35 trials
- Triple-negative breast cancer39 works · 13 trials
- Ovarian cancer33 works · 14 trials
- Cervical cancer23 works · 6 trials
- Brain metastases19 works · 1 trial
- Metastatic breast cancer19 works · 36 trials
- Diffuse large B-cell lymphoma9 works · 12 trials
- Follicular lymphoma5 works · 3 trials
Institution data: ROR 01f77gp95 (CC0-1.0)Updated 15 Nov 2026